FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

NCT00104884 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

NETWORK

Sponsor class

Stopped The study was terminated on May 17, 2006 due to slow accrual.

Conditions

Malignant Melanoma
Melanoma

Interventions

DRUG: Depsipeptide

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]